As verified by fluorescence immunohistochemistry, it seemed that predominant peripheral, presumably membranous localization of CD36 in +NASH-MSC livers changed to predominant cytoplasmic localization in +NASH+MSC-livers (Figure 2B). Here, CD36 is linked to metabolic dysfunction-associated steatohepatitis.